Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Epidermal growth factor receptor erbB1 antagonist PubMed

Cross References

Resources Reference
ChEMBL CHEMBL2109393